Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001682019-25-000003

Chief Executive Officer sold 13,081 shares at $58.15 ($760,660)

  • Chief Executive Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kulkarni Samarth Chief Executive Officer 2025-08-16 Option exercise +25,000 220,085 D
Kulkarni Samarth Chief Executive Officer 2025-08-18 Sale −13,081 $58.15 $760,660 207,004 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2025-08-16 Option exercise · Restricted Stock Units −25,000 0 D
Open-market sales · 13,081 sh · avg $58.15 · $760,660
Loading xslF345X05/ownership.xml…